from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1917c/PPE34

LFCtreatmentdescriptionclass of inhibitor

0.410

Amikacinug/mL Amikacintranslation

0.081

Cap5-10ug/mL Capreomycintranslation

0.505

Rox10-50 ug/mL Roxithromycintranslation

1.801

SM2-5 ug/mL Streptomycintranslation

-0.193

Tet5-10 ug/mL Tetracyclinetranslation

-0.463

Rif0.2-5ug/mL Rifampicintranscription

-0.178

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.363

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.547

CPZ10-50 ug/mL Chlorpromazinerespiration

0.000

Clofazimine10-13 ug/mL Clofaziminerespiration

0.638

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.550

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.000

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.823

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.138

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.747

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.900

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.000

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-1.189

Nigericin50 uM Nigericinrespiration

0.673

TRC10-150 ug/mL Triclosanrespiration

0.356

TRZ10-25 ug/mL Thioridazinerespiration

0.331

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.237

menadione6-10 ug/mL Menadionerespiration

-0.069

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.117

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.684

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.358

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.024

NRP_1Non-replicating persistence stage 1dosRassociated

-0.442

Amp0.2mg/mL AmpicillincellWall

-1.513

Cephalexin20-100 ug/mL CephalexincellWall

-0.039

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.129

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.427

EMB10-20 ug/mL EthambutolcellWall

-0.689

Eta12-40 ug/mL EthionamidecellWall

-0.732

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.182

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.674

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.894

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.110

BZA0.12 mg/mL BenzamidearomaticAmides

0.434

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.405

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

1.100

H2O24 mM hydrogen peroxideDNAdamaging

-0.674

Levo10 ug/mL LevofloxacinDNAdamaging

0.246

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.216

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.112

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.691

UVUV-irradiationDNAdamaging

0.000

ARP41-4 ug/mL Antitubercular compound ARP4?

0.895

Antimycin12.5-50 ug/mL Antimycin A?

-0.579

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.255

PA_110-50 ug/mL Antitubercular compound PA-1?

0.274

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.217

PA8240.2-2 ug/mL PA-824?

-0.335

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.514

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.388

Verapamil50 uM Verapamil?

0.000

mercaptoethanol2 mM 2-Mercaptoethanol?

0.173

methoxatin10-20 ug/mL Methoxatin?